(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Catholic influencer shares death of 5-year-old son from 'severe' flu - 2Kaiser Permanente affiliates to pay $556 million to resolve US claims alleging Medicare fraud
- 3Poland open to German troops to help secure Ukraine ceasefire
- 4The most effective method to Pick the Ideal Lab Precious stone Wedding band
- 5Winter virus season so far is not too bad, but doctors worry about suffering to come
- Discovering a sense of harmony: Individual Accounts of Reflection and Care
- Find the Keys to Fruitful Venture The board: Conveying Results on Time
- The Response to Independence from the rat race: Methodologies for Creating Financial momentum
- Bennu asteroid samples provide clues about solar system origins and 'space gum'
- Vote In favor of Your Favored Web-based Visual depiction Administration
- At least 171 measles cases confirmed in 9 states, CDC data shows
- A definitive Frozen yogurt Standoff: Which Flavor Rules?
- Benedict Cumberbatch takes on something even Sherlock can’t solve: male grief
- VPN Administrations for Online Protection
